Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2604 of 6351
-
Could an arthritis drug stop asthma attacks in their tracks?
Symptom relief Not yet recruitingIn this single center, interventional pilot study, 40 participants at high risk for future exacerbation will be randomized to anakinra (v. placebo control) treatment for home administration as part of an asthma action plan (AAP) and monitored through their first moderate asthma e…
Phase 1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can checking blood pressure at home improve pregnancy outcomes?
Disease control Not yet recruitingWe hypothesize that frequent remote monitoring of blood pressure and real-time antihypertensive medication titration will optimize pregnancy outcomes in a clinically meaningful and cost-effective manner compared to the current standard of care. Therefore, this pilot study, as par…
Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a ventilator setting skew energy readings in the ICU?
Knowledge-focused Not yet recruitingIndirect calorimetry is used in intensive care to measure how much oxygen a patient consumes and how much carbon dioxide is produced. These measurements are used to estimate energy expenditure and help guide nutritional treatment. In mechanically ventilated patients, however, ven…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Could a chicory root fiber soothe your aching knees?
Symptom relief Not yet recruitingThis study will test whether inulin, a type of dietary fiber, can reduce inflammation in older adults with knee osteoarthritis. Inflammation in the body may contribute to both joint pain and the progression of osteoarthritis. Inulin is a prebiotic fiber that may improve gut healt…
Phase 2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Estrogen patch may ease hot flashes in prostate cancer treatment
Symptom relief Not yet recruitingThis phase II trial compares giving estrogen with an androgen receptor signaling inhibitor to standard of care luteinizing hormone-releasing hormone (LHRH) analogues with an androgen receptor signaling inhibitor for improving quality of life for patients with hormone sensitive pr…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Corner pharmacy could be key to catching colon cancer early
Prevention Not yet recruitingColorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blo…
Sponsor: Monash University Malaysia • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
Smartphone videos could unlock secrets of rare brain disease
Knowledge-focused Not yet recruitingThis is a REMOTE prospective observational study of participants with MPS IIIC. No investigational medicinal product will be administered as part of this study. Patients functional abilities will be captured using video recordings taken by patients legal representative or careg…
Sponsor: Phoenix Nest • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New stent combo aims to prevent stroke in chinese patients
Disease control Not yet recruitingThe study is a prospective, non-randomized, single-arm, multi-center registry to confirm the safe delivery of the Carotid WALLSTENT Endoprosthesis when used with the ENROUTE® Transcarotid Neuroprotection System in the Chinese population
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can video diaries help black women access HIV prevention?
Prevention Not yet recruitingThe primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Black Women (BW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a hi…
Early phase 1 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Could a steroid eye drop help heal corneal ulcers faster?
Symptom relief Not yet recruitingThe investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.
Phase 2 • Sponsor: Vishal Jhanji • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New injections aim to quiet phantom limb pain
Symptom relief Not yet recruitingPostamputation pain is a complex condition that includes phantom limb pain (PLP), stump pain and residual limb pain (RLP), the latter of which may be referred from joints, the spine and inflamed bursa and tendons. PLP may have peripheral, spinal and central etiologies. The eviden…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
New drug trial aims to tame rare inflammatory disease in kids
Disease control Not yet recruitingThe primary objectives of this study are to characterize the pharmacokinetics (PK) and pharmacodynamics (PD), as well as to assess the safety and tolerability, of inebilizumab in pediatric participants with IgG4-RD.
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New study tests whether community workshops can lower lead levels in city dwellers
Prevention Not yet recruitingThis clinical trial aims to evaluate the effectiveness of targeted public health campaigns in reducing lead exposure among adults living in urban communities with known environmental lead hazards. Lead exposure remains a significant public health concern, particularly in older ur…
Sponsor: International Health Strategies LLC • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
New drug cevostamab enters early human testing for lupus
Disease control Recruiting nowThe study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cevostamab in participants with systemic lupus erythematosus (SLE) with or without active lupus nephritis (LN).
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New antibiotic combo tested in kids to fight superbug infections
Disease control Recruiting nowThe goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinet…
Phase 1 • Sponsor: Innoviva Specialty Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Lupus drug anifrolumab tested as a simple shot
Disease control Not yet recruitingThe purpose of this study is to assess the PK, PD, and safety of anifrolumab as SC administration or IV infusion in adult participants with systemic lupus erythematosus (SLE).
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New program aims to keep teens safe from gun injuries
Prevention Not yet recruitingOver the past three decades, substantial resources have been devoted to developing youth violence prevention (YVP) programs. These programs have demonstrated positive effects on reducing aggression and related behaviors, firearm-specific risk factors were largely overlooked due t…
Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
New radioactive antibody could light up Hard-to-Treat cancers
Diagnosis Not yet recruitingLNTH-2403 (177Lu-DOTA-DUNP19) is a lutetium-177 radiolabeled, fully humanized monoclonal antibody (mAb) that binds with high specificity and affinity to leucine-rich repeat containing 15 (LRRC15), a transforming growth factor (TGF) - β-driven biomarker expressed on the cell membr…
Phase 1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Which drug works best for sick newborns? small trial aims to find out
Disease control Recruiting nowThis pilot randomized clinical trial compares dopamine and norepinephrine as first-line vasoactive therapies in term and late preterm neonates with pulmonary hypertension associated with hypoxemic respiratory failure and systemic hypotension. Systemic hypotension is a common and …
Phase 4 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Liver health may change how cancer drug works
Knowledge-focused Not yet recruitingTo evaluate the pharmacokinetics and safety of Larotinib in subjects with mild and moderate hepatic function impairment and healthy subjects in a single-center, non-randomized, open, single-dose administration
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC